Game Creek Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Game Creek Capital's LLY Position: Q2 2026 in Review
Game Creek Capital reduced its Eli Lilly (LLY) stake by 23% in Q2 2026, selling an estimated $1.59M and leaving 5,070 shares worth $6.08M. The position accounts for 2.15% of the portfolio, ranked #13.
Game Creek Capital first reported a position in LLY in Q4 2017 and has held it in 6 quarters since. The position peaked at $7.25M in Q4 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Game Creek Capital held 5,070 shares of Eli Lilly worth $6.08M as of Q2 2026.
- Game Creek Capital sold 1,555 Eli Lilly shares in Q2 2026, an estimated $1.59M.
- Eli Lilly made up 2.15% of Game Creek Capital's portfolio in Q2 2026, its #13 holding.
- Game Creek Capital first reported a position in Eli Lilly in Q4 2017 and has held it in 6 quarters since.
- Game Creek Capital's Eli Lilly position peaked at $7.25M in Q4 2025.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Game Creek Capital's 13F filing for Q2 2026, filed 13 Aug 2026.